Clover Health Investments Return on Equity (ROE) Growth & History (CLOV)
Clover Health Investments's return on equity was −26.33% for fiscal 2025.
View full Clover Health Investments company overviewClover Health Investments annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −26.33% | −12.62 pp |
| 2024 | 2024-12-31 | −13.71% | +52.63 pp |
| 2023 | 2023-12-31 | −66.34% | +9.78 pp |
| 2022 | 2022-12-31 | −76.11% | — |
Clover Health Investments quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.82% | +10.93 pp |
| Q1 2026 | 2026-03-31 | 8.43% | +8.81 pp |
| Q4 2025 | 2025-12-31 | −15.18% | −8.72 pp |
| Q3 2025 | 2025-09-30 | −7.12% | −4.37 pp |
| Q2 2025 | 2025-06-30 | −3.11% | −5.51 pp |
| Q1 2025 | 2025-03-31 | −0.38% | +6.25 pp |
| Q4 2024 | 2024-12-31 | −6.47% | +16.71 pp |
| Q3 2024 | 2024-09-30 | −2.74% | +9.97 pp |
| Q2 2024 | 2024-06-30 | 2.40% | +11.22 pp |
| Q1 2024 | 2024-03-31 | −6.62% | +14.73 pp |
| Q4 2023 | 2023-12-31 | −23.17% | −0.68 pp |
| Q3 2023 | 2023-09-30 | −12.71% | +5.72 pp |
| Q2 2023 | 2023-06-30 | −8.82% | +13.95 pp |
| Q1 2023 | 2023-03-31 | −21.35% | −6.63 pp |
| Q4 2022 | 2022-12-31 | −22.49% | +17.18 pp |
| Q3 2022 | 2022-09-30 | −18.44% | −8.84 pp |
| Q2 2022 | 2022-06-30 | −22.77% | +48.13 pp |
| Q1 2022 | 2022-03-31 | −14.73% | — |
| Q4 2021 | 2021-12-31 | −39.67% | — |
| Q3 2021 | 2021-09-30 | −9.60% | −264.76 pp |
| Q2 2021 | 2021-06-30 | −70.90% | −286.70 pp |
| Q3 2020 | 2020-09-30 | 255.16% | — |
| Q2 2020 | 2020-06-30 | 215.80% | — |
Clover Health Investments return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Clover Health Investments's return on equity increased from −76.11% to −26.33%, a change of +49.78 percentage points. The latest reported quarter, Q2 2026, shows 7.82%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Clover Health Investments source filings ↗